Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.
about
Early pulmonary response is critical for extra-pulmonary carbon nanoparticle mediated effects: comparison of inhalation versus intra-arterial infusion exposures in miceToxic effects and biodistribution of ultrasmall gold nanoparticles.Where Do Inhaled Fossil Fuel-derived Particles Go?Ambient air pollution and thrombosis.Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and In Vitro/In Vivo Toxicity Evaluation.Particulate Matter Air Pollution and the Risk of Incident CKD and Progression to ESRD.Aging Exacerbates Neuroinflammatory Outcomes Induced by Acute Ozone Exposure.Children's Urinary Environmental Carbon Load. A Novel Marker Reflecting Residential Ambient Air Pollution Exposure?The variability of PM10 and PM2.5 concentrations in selected Polish agglomerations: the role of meteorological conditions, 2006-2016.Lipophilic components of diesel exhaust particles induce pro-inflammatory responses in human endothelial cells through AhR dependent pathway(s).Lipophilic Chemicals from Diesel Exhaust Particles Trigger Calcium Response in Human Endothelial Cells via Aryl Hydrocarbon Receptor Non-Genomic Signalling.Air Pollution and Stroke.Effectiveness of face masks used to protect Beijing residents against particulate air pollution.Pilot study on biocompatibility of fluorescent nanodiamond-(NV)-Z~800 particles in rats: safety, pharmacokinetics, and bio-distribution (part III)Combustion-derived particles inhibit in vitro human lung fibroblast-mediated matrix remodelingNanoparticles Can Wrap Epithelial Cell Membranes and Relocate Them Across the Epithelial Cell Layer
P2860
Q33823484-46853F29-9757-4E66-B6A9-8DFE7757C701Q39431975-EC17AA7A-ABCF-4C26-9549-2B7D862D3AE1Q46329316-3EA6A461-709F-4530-A103-54EE46EC7732Q47102781-BFC147AC-46FF-42D8-9B1C-DD5B25CC0EE2Q47169890-CCD970B0-2ECF-4EA6-A5CD-8C11FD0E03D3Q47684124-608881F5-C898-41DE-87E7-A7C42A7D7698Q47829097-6DA2E1CD-2789-441E-8B47-D6C1C496D538Q48160209-6549CF91-7B59-484A-B144-8689B5F8C271Q49997645-2A796B5B-BBA0-4902-B81F-7B98870A94DFQ54214243-58199959-74EC-432E-84D7-E7531A02638EQ54214975-5D743251-88A9-4669-8383-B4C66B4BEF71Q55097512-05E18289-7D9D-4BF1-9290-E178232B3A77Q55347810-54E70EF8-FDE1-4F2D-A2D3-CBD1CD56626DQ57074406-2C7DB0AE-9AED-44C0-87C8-2374C5F09A46Q58111450-90CA9069-4182-4918-B11E-3251372E643EQ58833824-0ACCE7E2-3BB4-447B-9707-9E9A095420D3
P2860
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.
@en
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.
@nl
type
label
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.
@en
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.
@nl
prefLabel
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.
@en
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease
@en
P2093
A John F Boere
Alex T Vesey
Colin J Campbell
David E Newby
Flemming R Cassee
Jennifer B Raftis
Jeremy P Langrish
Ken Donaldson
Patrick W F Hadoke
Paul H B Fokkens
P2860
P304
P356
10.1021/ACSNANO.6B08551
P407
P577
2017-04-26T00:00:00Z